BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 21, 2026
See today's BioWorld Asia
Home
» Med-tech financings steady at $8.8B in Q1, despite volume drop
To read the full story,
subscribe
or
sign in
.
Med-tech financings Q1 2026
Med-tech financings steady at $8.8B in Q1, despite volume drop
April 21, 2026
By
Amanda Lanier
No Comments
Total med-tech financings reached $8.81 billion in the first quarter (Q1) 2026, a 6% decline from $9.33 billion in Q1 2025 but well above the post-downturn lows of recent years.
BioWorld Asia
Analysis and data insight
Financings
Medical technology
IPO
Asia-Pacific
